BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15317144)

  • 21. Trials and tribulations: new pressure on drug companies to reveal all about their clinical tests.
    Economist; 2004 Jun; 371(8380):62-3. PubMed ID: 15457617
    [No Abstract]   [Full Text] [Related]  

  • 22. DSM-5: riddled with conflicts of interest.
    Prescrire Int; 2015 Jan; 24(156):4. PubMed ID: 25729820
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugmakers prefer silence on test data; firms violate US law by not registering trials.
    Vedantam S
    Washington Post; 2004 Jul; ():A1, A4. PubMed ID: 15290815
    [No Abstract]   [Full Text] [Related]  

  • 24. Spitzer sues drug giant for deceiving doctors.
    Wadman M
    Nature; 2004 Jun; 429(6992):589. PubMed ID: 15190317
    [No Abstract]   [Full Text] [Related]  

  • 25. Public registration of clinical trials.
    Steinbrook R
    N Engl J Med; 2004 Jul; 351(4):315-7. PubMed ID: 15269307
    [No Abstract]   [Full Text] [Related]  

  • 26. Congress may force drug firms to reveal clinical trial data.
    Check E
    Nature; 2004 Sep; 431(7006):232. PubMed ID: 15371992
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug companies, doctors and disclosures.
    Tuorto S; Chan MK; Adusumilli PS
    Natl Med J India; 2004; 17(4):215-6. PubMed ID: 15372772
    [No Abstract]   [Full Text] [Related]  

  • 28. Registration of clinical trials--voluntary or mandatory?
    Steinbrook R
    N Engl J Med; 2004 Oct; 351(18):1820-2. PubMed ID: 15509812
    [No Abstract]   [Full Text] [Related]  

  • 29. Paxil study under fire.
    Wadman M
    Nature; 2011 Jul; 475(7355):153. PubMed ID: 21753826
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug giants fail to name compounds in trial database.
    Wadman M
    Nature; 2005 Jun; 435(7042):548. PubMed ID: 15931185
    [No Abstract]   [Full Text] [Related]  

  • 31. Trials, tricks and transparency: how disclosure rules affect clinical knowledge.
    Dahm M; González P; Porteiro N
    J Health Econ; 2009 Dec; 28(6):1141-53. PubMed ID: 19782416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Globalized clinical trials and informed consent.
    Annas GJ
    N Engl J Med; 2009 May; 360(20):2050-3. PubMed ID: 19439740
    [No Abstract]   [Full Text] [Related]  

  • 33. The old file-drawer problem.
    Kennedy D
    Science; 2004 Jul; 305(5683):451. PubMed ID: 15273363
    [No Abstract]   [Full Text] [Related]  

  • 34. Closing a loophole in the FDA Amendments Act.
    Turner EH
    Science; 2008 Oct; 322(5898):44-6. PubMed ID: 18832629
    [No Abstract]   [Full Text] [Related]  

  • 35. UK drugs industry sets up trials register.
    Kmietowicz Z
    BMJ; 2000 Oct; 321(7265):850. PubMed ID: 11021851
    [No Abstract]   [Full Text] [Related]  

  • 36. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guinea-pigging.
    Elliott C
    Minn Med; 2008 Apr; 91(4):32-6. PubMed ID: 18549005
    [No Abstract]   [Full Text] [Related]  

  • 38. Your health in the 21st century. Getting all the facts on drugs.
    Drazen JM
    Newsweek; 2005; 145(26A):72. PubMed ID: 16375153
    [No Abstract]   [Full Text] [Related]  

  • 39. European drug agency calls for more ethical trials in developing countries.
    Day M
    BMJ; 2010 Sep; 341():c4984. PubMed ID: 20833751
    [No Abstract]   [Full Text] [Related]  

  • 40. Time to nip "seeding trials" in the bud.
    Katz KA
    Arch Dermatol; 2008 Mar; 144(3):403-4. PubMed ID: 18347299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.